Guillain-barre Syndrome is a rare disorder that affects the peripheral nervous system. This condition is triggered by an immune system attack on the myelin sheath, which is the protective coating surrounding nerve fibers. The symptoms of Guillain-barre Syndrome start with tingling and weakness in the feet and legs, …
Guillain-barre Syndrome is a rare disorder that affects the peripheral nervous system. This condition is triggered by an immune system attack on the myelin sheath, which is the protective coating surrounding nerve fibers. The symptoms of Guillain-barre Syndrome start with tingling and weakness in the feet and legs, which then spread to the upper body and arms. As the condition progresses, the patient may experience difficulty breathing and may require artificial ventilation to stay alive. While the exact cause of Guillain-barre Syndrome is not fully understood, it is thought to be related to viral or bacterial infections, such as the flu or campylobacteriosis, or vaccinations. There is currently no cure for Guillain-barre Syndrome, but there are therapies available to manage the symptoms and improve the patient's quality of life. Treatment options include plasma exchange, which is a process of removing the patient's blood plasma and replacing it with donor plasma, and immunoglobulin therapy, which involves administering antibodies to neutralize the immune system's attack on the nervous system. If you or someone you know is experiencing symptoms of Guillain-barre Syndrome, it is crucial to seek medical attention immediately. Early diagnosis and treatment can increase the chances of a full recovery. Additionally, it is important to note that while Guillain-barre Syndrome can be a severe condition, many people do recover completely with proper care and treatment.
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 2 articles above have been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Guillain-barre Syndrome, linking to each citing work.